Clinical research is a key driver of medical innovation and public health improvement.
In Madagascar, this field is still emerging. However, discussions at the 20th Indian Ocean HIV Colloquium, particularly during the roundtable we led, highlighted both current challenges and promising prospects for sponsors and investigators willing to engage.
At the table, we exchanged views with representatives from the Ethics Committee, the Malagasy Medicines Agency, field investigators, the Institut Pasteur de Madagascar, and the National Institute of Public and Community Health. These perspectives allow us to provide a realistic yet forward-looking assessment.
An Emerging Context
Currently, Madagascar represents a small fraction of clinical trials registered internationally (37 in ClinicalTrials.gov, 85 in the WHO ICTRP). Research funding remains very limited (0.01% of GDP), yet growing interest from public and private institutions shows a genuine willingness to structure the field.
The country faces diverse health issues: HIV, tuberculosis, malaria, plague, as well as rising chronic conditions such as hypertension and diabetes. This diversity offers a broad scope for interventional and observational studies.
Key Challenges
- Infrastructure and Human Resources
Research sites remain limited, and the lack of qualified personnel requires investigators to train their own teams. However, this challenge also presents an opportunity: Madagascar is beginning to consider creating specialized training programs, such as a university diploma in clinical research, to professionalize the workforce. - Regulatory and Ethical Framework
Since 2016, Madagascar has had a National Ethics Committee for biomedical research, ensuring participant protection and adherence to international standards. The framework is gradually strengthening, although some procedures still need refinement. Working with experienced providers ensures rapid solutions and smooth compliance. - Funding
Local funding is scarce, with most resources coming from international donors (USA, UK, EU). Strong partnerships are key to increasing visibility and attracting research projects.
Why Madagascar is an Opportunity
- Respectful and Collaborative Research – Participants are treated as true partners, providing valuable data within an ethical and internationally recognized framework.
- Innovation-Friendly Environment – The combination of infectious and emerging chronic diseases creates a unique setting to test new medical approaches.
- Growing Local Expertise – Madagascar has a developing pool of health professionals and researchers capable of conducting rigorous studies.
- Capacity-Building Momentum – Institutes and hospitals (Institut Pasteur, Charles Mérieux Infectiology Center, CHU Befelatanana, CHU Fianarantsoa, CHU Toamasina…) train their own teams, and the Public Health Master’s program includes clinical research modules.
- Openness to International Collaboration – Authorities are integrating clinical research into national priorities, offering sponsors a less competitive but high-potential environment.
Role of Local Partners
Since 2020, Pharmaspecific has strengthened local skills through clinical research training. This presence allows us to guide sponsors in:
- Clinical trial coordination (TEC, data management, monitoring) and compliance review (audit)
- Regulatory support with authorities
- Patient logistics and support (reimbursement, concierge, transport, accommodation)
Conclusion
Clinical research in Madagascar is at a pivotal moment. Challenges exist – infrastructure, funding, regulatory consolidation – but they come with significant opportunities: easier recruitment, relevant research topics, mobilized institutions, and reliable local partners.
Investing in clinical research in Madagascar today contributes to medical progress while building a dynamic, agile, and forward-looking scientific environment. Madagascar has the potential to become a regional hub, and we are ready to support sponsors who wish to be part of this development.
Need support for your projects? Pharmaspecific operates in France and Madagascar. If you require a Clinical Research Associate (CRA) or Clinical Research Technician (CRC) for a defined period, help with regulatory submissions, patient reimbursement, or managing unique contracts, contact us at +33 9 87 04 64 92 or send a private message.
Discover our services 👉🏽 www.pharmaspecific.com
